复星医药(02196.HK)：盐酸莫托咪酯注射液的药品注册申请获受理

Core Viewpoint - Fosun Pharma's subsidiary, Jinzhou Aohong Pharmaceutical, has received acceptance for its drug registration application for Mivacurium Injection from the National Medical Products Administration, targeting anesthesia induction and short-term surgical anesthesia [1] Group 1 - The drug registration application is classified as a Class 1 chemical drug [1] - The project code for the Mivacurium Injection is ET-26 [1] - The intended indications for the drug include use in anesthesia induction and short-term surgical anesthesia [1]